Comparative cost analysis of cervical cancer screening programme based on molecular detection of HPV in Spain

• Main Authors: R. Ibáñez (Author), M. Mareque (Author), R. Granados (Author), D. Andía (Author), M. García-Rojo (Author), J. C. Quílez (Author), I. Oyagüez (Author)
• Format: Book
• Published: BMC, 2021-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background HPV cervical cancer screening (CCS) must use validated HPV tests based on the molecular detection of either viral mRNA (Aptima HPV Assay-AHPV) or DNA. AHPV has demonstrated the same cross-sectional and longitudinal sensitivity for the detection of HSIL/CIN2+ lesions but with grea...